» Articles » PMID: 16807245

Serglycin is the Major Secreted Proteoglycan in Macrophages and Has a Role in the Regulation of Macrophage Tumor Necrosis Factor-alpha Secretion in Response to Lipopolysaccharide

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Jun 30
PMID 16807245
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

It has recently been shown that serglycin is essential for maturation of mast cell secretory granules. However, serglycin is expressed also by other cell types, and in this study we addressed the role of serglycin in macrophages. Adherent cells were prepared from murine peritoneal cell populations and from spleens, and analyzed for proteoglycan synthesis by biosynthetic labeling with [35S]sulfate. Conditioned media from serglycin-/- peritoneal macrophages and adherent spleen cells displayed a 65-80% reduction of 35S-labeled proteoglycans, compared with corresponding material from serglycin+/+ cells, indicating that serglycin is the dominant secretory proteoglycan in macrophages of these origins. In contrast, the levels of intracellular proteoglycans were similar in serglycin+/+ and serglycin-/- cells, suggesting that serglycin is not stored intracellularly to a major extent in macrophages. This is in contrast to mast cells, in which serglycin is predominantly stored intracellularly. Transmission electron microscopy revealed that the absence of serglycin did not cause any major morphological effects on peritoneal macrophages, in contrast to dramatic defects in intracellular storage vesicles in peritoneal mast cells. Several secretory products were not found to be affected by the lack of serglycin. However, the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide stimulation was markedly higher in serglycin-/- cultures than in those of serglycin+/+. The present report thus demonstrates that serglycin is the major proteoglycan secreted by peritoneal macrophages and suggests that the macrophage serglycin may have a role in regulating secretion of tumor necrosis factor-alpha.

Citing Articles

Comprehensive investigation of proteoglycan gene expression in breast cancer: Discovery of a unique proteoglycan gene signature linked to the malignant phenotype.

Buraschi S, Pascal G, Liberatore F, Iozzo R Proteoglycan Res. 2025; 3(1).

PMID: 40066261 PMC: 11893098. DOI: 10.1002/pgr2.70014.


Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow.

Lykins J, Becker I, Camacho V, Alfar H, Park J, Italiano J Blood Adv. 2024; 9(1):15-28.

PMID: 38941534 PMC: 11732581. DOI: 10.1182/bloodadvances.2024012995.


Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis.

Piszczatowski R, Bulow H, Steidl U Blood. 2024; 143(25):2571-2587.

PMID: 38639475 PMC: 11830984. DOI: 10.1182/blood.2023022736.


Inflammatory, metabolic, and sex-dependent gene-regulatory dynamics of microglia and macrophages in neonatal hippocampus after hypoxia-ischemia.

Di Martino E, Ambikan A, Ramskold D, Umekawa T, Giatrellis S, Vacondio D iScience. 2024; 27(4):109346.

PMID: 38500830 PMC: 10945260. DOI: 10.1016/j.isci.2024.109346.


SRGN amplifies microglia-mediated neuroinflammation and exacerbates ischemic brain injury.

Qian Y, Yang L, Chen J, Zhou C, Zong N, Geng Y J Neuroinflammation. 2024; 21(1):35.

PMID: 38287411 PMC: 10826034. DOI: 10.1186/s12974-024-03026-6.